These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Role of BDNF in the pathophysiology and treatment of depression: Activity-dependent effects distinguish rapid-acting antidepressants. Duman RS; Deyama S; Fogaça MV Eur J Neurosci; 2021 Jan; 53(1):126-139. PubMed ID: 31811669 [TBL] [Abstract][Full Text] [Related]
23. Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine. Yao W; Cao Q; Luo S; He L; Yang C; Chen J; Qi Q; Hashimoto K; Zhang JC Mol Psychiatry; 2022 Mar; 27(3):1618-1629. PubMed ID: 34819637 [TBL] [Abstract][Full Text] [Related]
24. Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation. Qu X; Zhang X; Yao J; Song J; Nikolic-Paterson DJ; Li J J Pathol; 2012 Dec; 228(4):506-19. PubMed ID: 22610993 [TBL] [Abstract][Full Text] [Related]
25. The duration of the antidepressant-like effects of a single infusion of brain-derived neurotrophic factor into the medial prefrontal cortex in mice. Deyama S; Kaneda K Behav Brain Res; 2020 Sep; 394():112844. PubMed ID: 32745661 [TBL] [Abstract][Full Text] [Related]
26. Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites. Yang C; Yang J; Luo A; Hashimoto K Transl Psychiatry; 2019 Nov; 9(1):280. PubMed ID: 31699965 [TBL] [Abstract][Full Text] [Related]
27. Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse. Harrison JL; Rowe RK; Ellis TW; Yee NS; O'Hara BF; Adelson PD; Lifshitz J Brain Behav Immun; 2015 Jul; 47():131-40. PubMed ID: 25585137 [TBL] [Abstract][Full Text] [Related]
28. Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine. Deyama S; Bang E; Wohleb ES; Li XY; Kato T; Gerhard DM; Dutheil S; Dwyer JM; Taylor SR; Picciotto MR; Duman RS Am J Psychiatry; 2019 May; 176(5):388-400. PubMed ID: 30606046 [TBL] [Abstract][Full Text] [Related]
29. Ketamine: A tale of two enantiomers. Jelen LA; Young AH; Stone JM J Psychopharmacol; 2021 Feb; 35(2):109-123. PubMed ID: 33155503 [TBL] [Abstract][Full Text] [Related]
30. Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. Tian H; Lu Y; Sherwood AM; Hongqian D; Hong S Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3613-20. PubMed ID: 19443724 [TBL] [Abstract][Full Text] [Related]
32. Role of mTOR1 signaling in the antidepressant effects of ketamine and the potential of mTORC1 activators as novel antidepressants. Kato T Neuropharmacology; 2023 Feb; 223():109325. PubMed ID: 36334763 [TBL] [Abstract][Full Text] [Related]
33. Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex. Sales AJ; Fogaça MV; Sartim AG; Pereira VS; Wegener G; Guimarães FS; Joca SRL Mol Neurobiol; 2019 Feb; 56(2):1070-1081. PubMed ID: 29869197 [TBL] [Abstract][Full Text] [Related]
34. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. Park CK; Xu ZZ; Liu T; Lü N; Serhan CN; Ji RR J Neurosci; 2011 Dec; 31(50):18433-8. PubMed ID: 22171045 [TBL] [Abstract][Full Text] [Related]
35. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats. Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652 [TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine. Hashimoto K Biochem Pharmacol; 2020 Jul; 177():113935. PubMed ID: 32224141 [TBL] [Abstract][Full Text] [Related]
37. Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast in vitro. Salas-Hernández A; Espinoza-Pérez C; Vivar R; Espitia-Corredor J; Lillo J; Parra-Flores P; Sánchez-Ferrer CF; Peiró C; Díaz-Araya G Mol Biol Rep; 2021 Jan; 48(1):57-66. PubMed ID: 33459958 [TBL] [Abstract][Full Text] [Related]
38. Rapid and sustained antidepressant effects of resolvin D1 and D2 in a chronic unpredictable stress model. Ishikawa Y; Deyama S; Shimoda K; Yoshikawa K; Ide S; Satoh M; Minami M Behav Brain Res; 2017 Aug; 332():233-236. PubMed ID: 28610917 [TBL] [Abstract][Full Text] [Related]